Akebia Therapeutics Inc. (AKBA) announced after the bell Monday that it has entered into an exclusive license agreement with Vifor Pharma Group to sell vadadustat to Fresenius Medical Care dialysis clinics in the United States, once the FDA has approved them.
from RTT - Before the Bell http://ift.tt/2pKkGBP
via IFTTT
No comments:
Post a Comment